Caliso, Crisanto C.
HRN: 56-04-05 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/10/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/10/2024
10/17/2024
IV
600mg
IVq6
Infected Right Hand
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes